Skip to main navigation Skip to search Skip to main content

Do GLP-1 reeptor agonists have a place in the treatment of people with type 1 diabetes?

Thomas Fremming Dejgaard*, Christian S. Frandsen, Jens Juul Holst, Sten Madsbad

*Corresponding author for this work
Original languageEnglish
JournalMedical research archives
Volume12
Issue number12
ISSN2375-1924
DOIs
Publication statusPublished - 2024

Cite this